Upcoming Conferences in 2010     Please save the date for the following conference scheduled for 2010: Inhaled Nitric Oxide Therapy for Premature Infants Registration will be open six to nine months prior to each conference and additional information will be available at that time.  Please note that all conferences are free and open to the public. If you would like to be notified when registration opens and when the statement is available, please sign up for alerts at http://consensus.nih.gov/alerts.htm.     NIH Consensus Development Conference: Inhaled Nitric Oxide Therapy for Premature Infants October 27-29, 2010 Bethesda, Maryland Does inhaled nitric oxide (iNO) therapy increase survival and/or reduce the occurrence or severity of bronchopulmonary dysplasia (BPD) among premature infants who receive respiratory support? Are there short-term risks of iNO therapy among premature infants who receive respiratory support? Are there effects of iNO therapy on long-term pulmonary and/or neurodevelopmental outcomes among premature infants who receive respiratory support? Does the effect of iNO therapy on BPD and/or death or neurodevelopmental impairment vary across subpopulations of premature infants? Does the effect of iNO therapy on BPD and/or death or neurodevelopmental impairment vary by timing of initiation, mode of delivery, dose and duration, or concurrent therapies? What are the future research directions needed to better understand the risks, benefits, and alternatives to iNO therapy for premature infants who receive respiratory support? Back to top

Contact Consensus Program | Privacy Notice | Disclaimer | Accessibility | Contact NIH